Your browser doesn't support javascript.
loading
SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy.
Farhangnia, Pooya; Ghomi, Shamim Mollazadeh; Mollazadehghomi, Shabnam; Nickho, Hamid; Akbarpour, Mahzad; Delbandi, Ali-Akbar.
Afiliación
  • Farhangnia P; Immunology Research Center, Institute of Immunology and Infectious Disease, Iran University of Medical Sciences, Tehran, Iran.
  • Ghomi SM; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Mollazadehghomi S; Immunology Board for Transplantation and Cell-Based Therapeutics (ImmunoTACT), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Nickho H; Immunology Board for Transplantation and Cell-Based Therapeutics (ImmunoTACT), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Akbarpour M; Immunology Board for Transplantation and Cell-Based Therapeutics (ImmunoTACT), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Delbandi AA; Immunology Research Center, Institute of Immunology and Infectious Disease, Iran University of Medical Sciences, Tehran, Iran.
Front Immunol ; 14: 1174138, 2023.
Article en En | MEDLINE | ID: mdl-37251372
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígenos CD / Mieloma Múltiple Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Irán
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígenos CD / Mieloma Múltiple Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Irán